Silo pharma, inc. enters into an exclusive option agreement with the university of maryland, baltimore for patented homing peptides targeting rheumatoid arthritis

Silo plans to explore the use of psychedelics to target inflammation silo plans to explore the use of psychedelics to target inflammation

SILO Ratings Summary

SILO Quant Ranking